<DOC>
	<DOC>NCT02971436</DOC>
	<brief_summary>This study will investigate the efficacy of the FPH modified positive airway pressure (PAP) device with or without SensAwake; and with different pressure support in OSA participants; in both an in-home and in-lab environment. Comfort, compliance and the accuracy of the pressure delivery will also be evaluated. The FPH device will be compared to a market released product.</brief_summary>
	<brief_title>Evaluation of Treatment Efficacy of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Aged 18 and over Diagnosed with OSA by a practicing physician and prescribed Positive Airway Pressure (PAP) (Continuous Positive Airway Pressure (CPAP) or AutoCPAP). Participants can be na√Øve to CPAP or experienced users of CPAP. For experienced users of PAP (CPAP or AutoCPAP): Using the PAP of more than 4 hours/night for 70% during the last 30 days (justification allowed by the investigator) Contraindicated for PAP (CPAP or AutoCPAP) therapy Persons with other significant sleep disorder(s) (e.g periodic leg movements, insomnia, central sleep apnea) Persons with obesity hypoventilation syndrome or congestive heart failure. Persons that require supplemental oxygen with their PAP (CPAP or AutoCPAP) device Persons with implanted electronic medical device (e.g cardiac pacemakers) Persons who are pregnant or think they might be pregnant.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>